Numerous clinical trials have demonstrated the effectiveness of GLP-1 medications in promoting weight loss and improving metabolic health in both diabetic and non-diabetic patients
conducted an analysis of the long-term effectiveness of liraglutide and glimepiride monotherapies in patients with DM from the LEAD-3 trial ( In a pilot study, Jaiswal et al
Grisendi G, Finetti E, Manganaro D, Cordova N, Montagnani G, Spano C, et al
Meta-analyses and systematic reviews report that MI alone or combined with DCI in a 40:1 ratio may help support ovulation frequency, menstrual regularity, insulin sensitivity, and some hormone-related markers in people with PCOS.1 2 3 31 That said, responses vary, and improvements tend to be gradual rather than dramatic.17 People seeking fertility or egg-quality support Inositol has been studied in fertility and assisted reproductive settings, where it appears to support oocyte maturation and ovarian responsiveness particularly in people with PCOS or insulin-related reproductive dysfunction.27 28 45 Some studies report improvements in egg quality and fertilization outcomes with consistent use, though evidence is strongest in PCOS populations and more limited in people without underlying metabolic or hormonal concerns.17 Pregnant individuals at risk for gestational diabetes Several clinical trials and meta-analyses suggest that myo-inositol supplementation during pregnancy may reduce the risk of gestational diabetes in people who are already considered higher risk.9 24 25 26 45 Because pregnancy is a unique physiological state, decisions about inositol supplementation during pregnancy should be made with guidance from a healthcare professional familiar with your medical history
